Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 18, 2011

EUTOS Score Superior in Predicting CML Treatment Response

Blood

 

Additional Info

Blood
Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score
Blood 2011 May 02;[EPub Ahead of Print], J Hasford, M Baccarani, V Hoffmann, J Guilhot, S Saussele, G Rosti, F Guilhot, K Porkka, G Ossenkoppele, D Lindoerfer, B Simonsson, M Pfirrmann, R Hehlmann

Further Reading